Midatech files CTA for MTD201 ’s carcinoid cancer and acromegaly trial

UK-based specialist pharmaceutical firm Midatech Pharma has submitted a clinical trial application (CTA) for its drug candidate MTD201 to treat carcinoid cancer and acromegaly.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news